On a similar note, RGC-32 deficiency in mice has been shown to significantly improve skin and lung fibrosis (sclerosis) by inhibiting the expression of inducible NO synthase (iNOS) and IL-1β in macrophages [35]. Here, RGCC is linked to pulmonary fibrosis.